TMCITREACE MEDICAL CONCEPTS, INC.

Nasdaq treace.com


$ 5.88 $ 0.13 (2.26 %)    

Friday, 31-May-2024 15:59:58 EDT
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 5.88
$ 5.86
$ 5.87 x 511
$ 5.90 x 100
$ 5.71 - $ 6.16
$ 3.92 - $ 27.41
1,844,098
na
363.34M
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-08-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 03-04-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-25-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-downgrades-treace-medical-concepts-to-neutral-lowers-price-target-to-65

UBS analyst Danielle Antalffy downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Neutral and lowers the price targ...

 orthopedic-devices-maker-treace-medical-concepts-gloomy-forecast-cast-concerns-over-long-term-viability

Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to e...

 morgan-stanley-downgrades-treace-medical-concepts-to-equal-weight-lowers-price-target-to-55

Morgan Stanley analyst Drew Ranieri downgrades Treace Medical Concepts (NASDAQ:TMCI) from Overweight to Equal-Weight and low...

 ubs-maintains-buy-on-treace-medical-concepts-lowers-price-target-to-16

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and lowers the price target from $1...

 truist-securities-downgrades-treace-medical-concepts-to-hold-lowers-price-target-to-7

Truist Securities analyst Richard Newitter downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Hold and lowers the ...

 jp-morgan-downgrades-treace-medical-concepts-to-neutral-lowers-price-target-to-8

JP Morgan analyst Robbie Marcus downgrades Treace Medical Concepts (NASDAQ:TMCI) from Overweight to Neutral and lowers the p...

 btig-downgrades-treace-medical-concepts-to-neutral

BTIG analyst Ryan Zimmerman downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Neutral.

 stifel-downgrades-treace-medical-concepts-to-hold-lowers-price-target-to-6

Stifel analyst Rick Wise downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Hold and lowers the price target from ...

 treace-medical-concepts-q1-2024-gaap-eps-030-beats-031-estimate-sales-51108m-beat-49065m-estimate

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION